Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01965184
Other study ID # 0102012121-C
Secondary ID R01MH101514
Status Completed
Phase N/A
First received
Last updated
Start date November 14, 2013
Est. completion date November 3, 2018

Study information

Verified date November 2023
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized controlled study of cognitive-behavioral therapy (CBT) for disruptive behavior such as irritability, anger and aggression in children and adolescents. CBT will be compared to Supportive Psychotherapy (SPT) and participants of this study will be randomly assigned (like the flip of a coin) to receive CBT or SPT. Participants will be also asked to complete functional magnetic resonance imaging (fMRI) and electrophysiological (EEG) tasks (recordings/images of brain activity) before and after treatment.


Description:

Cognitive-behavioral therapy (CBT) is a behavioral intervention that consists of 12 weekly sessions. During CBT children are taught various skills for coping with frustration and parents are taught various strategies for managing situations that can be anger provoking for their child. This study is conducted to examine whether reduction of behavioral problems including anger outbursts, irritability, aggression and noncompliance after CBT may be paralleled by changes in areas of the brain responsible for emotion regulation and social perception.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date November 3, 2018
Est. primary completion date August 3, 2018
Accepts healthy volunteers No
Gender All
Age group 8 Years to 16 Years
Eligibility Inclusion Criteria: 1. Boys and girls, 8 to 16 years of age. 2. T-Score > 65 on the parent-rated Aggressive Behavior Scale of the Child Behavior Checklist (CBCL). 3. Unmedicated or on stable medication for aggression, ADHD, anxiety, or depression for at least 6 weeks, with no planned changes for duration of study. 4. Children can speak English sufficiently enough to participate in CBT and study assessments. 5. Children should have 1) no metal medical implants, 2) a body weight of less than 250 lbs. and 3) no claustrophobia. [These are necessitated by the safety requirements of the fMRI.] 6. Children should be able to meet fMRI data quality requirements at baseline [to enable pre- to post-treatment comparison.] 7. Families can commute to the Yale Child Study Center in New Haven, CT for weekly visits. Exclusion Criteria: 1. IQ below 85. 2. Children across various DSM diagnoses will be eligible for participation. However, significant levels of psychopathology that require immediate clinical attention such as severe depression or psychosis will be exclusionary because it will require alternative treatments. 3. Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder, brain injury based on medical history which can interfere with participation in the study. 4. Concurrent psychotherapy can continue, but CBT for aggression is exclusionary. Subjects will be asked not to initiate any new child psychotherapy during the study.

Study Design


Intervention

Behavioral:
Cognitive-Behavioral Therapy for Anger and Aggression

Supportive Psychotherapy (SPT)


Locations

Country Name City State
United States Yale University New Haven Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Yale University National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Perlman SB, Pelphrey KA. Developing connections for affective regulation: age-related changes in emotional brain connectivity. J Exp Child Psychol. 2011 Mar;108(3):607-20. doi: 10.1016/j.jecp.2010.08.006. Epub 2010 Oct 23. — View Citation

Sukhodolsky DG, Vitulano LA, Carroll DH, McGuire J, Leckman JF, Scahill L. Randomized trial of anger control training for adolescents with Tourette's syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):413-421. doi: 10.1097/CHI.0b013e3181985050. — View Citation

Sukhodolsky, D. G. & Scahill, L. (2012). Cognitive-behavioral therapy for anger and aggression in children. New York: Guilford Press.

Outcome

Type Measure Description Time frame Safety issue
Other functional magnetic resonance imaging (fMRI) fMRI scanning with tasks of emotion regulation and social perception baseline (week 0)
Other Electroencephalography (EEG) EEG recordings will be collected as participants perform tasks of emotion regulation and social perception baseline (week 0)
Other functional magnetic resonance imaging (fMRI) fMRI scanning with tasks of emotion regulation and social perception endpoint (week 12)
Other Electroencephalography (EEG) EEG recordings will be collected as participants perform tasks of emotion regulation and social perception endpoint (week 12)
Primary Modified Overt Aggression Scale Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome. basline (week 0)
Primary Modified Overt Aggression Scale Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome. midpoint (week 6)
Primary Modified Overt Aggression Scale Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome. endpoint (week 12)
Primary Modified Overt Aggression Scale Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome. follow up (3 months)
Primary The Clinical Global Impression - Improvement Score The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response. basline (week 0)
Primary The Clinical Global Impression - Improvement Score The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response. midpoint (week 6)
Primary The Clinical Global Impression - Improvement Score The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response. endpoint (week 12)
Primary The Clinical Global Impression - Improvement Score The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response. follow up (3 months)
Secondary The Child Behavior Checklist The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range. basline (week 0)
Secondary The Child Behavior Checklist The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range. midpoint (week 6)
Secondary The Child Behavior Checklist The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range. endpoint (week 12)
Secondary The Child Behavior Checklist The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range. follow up (3 months)
See also
  Status Clinical Trial Phase
Completed NCT02552147 - Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism Phase 1
Completed NCT02485587 - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents N/A
Active, not recruiting NCT01792167 - Multi-Site Evaluation of Second Step N/A
Completed NCT00361062 - Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment N/A
Completed NCT00455234 - Rapid Tranquillization Trial: TREC-India II Phase 3
Completed NCT00000385 - Long-Term Lithium Treatment for Aggressive Conduct Disorder Phase 3
Not yet recruiting NCT03672942 - Communication Skills vs. Mindfulness for IPV N/A
Recruiting NCT04732052 - The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities N/A
Terminated NCT02483572 - Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control N/A
Completed NCT04097431 - Identifying Precursors to Severe Problem Behavior N/A
Completed NCT04130360 - A Trial of an Online Problem-solving Intervention for Aggression N/A
Completed NCT02563145 - Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents N/A
Completed NCT00510094 - Effectiveness of Treatment for Relational Aggression in Urban African American Girls Phase 3
Recruiting NCT03430973 - Aggressive Driving and Road Rage: A Driving Simulation Experiment. N/A
Completed NCT03693209 - Using Implementation Intentions to Reduce Anger and Aggression in Adolescence N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Completed NCT03784846 - Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers N/A
Active, not recruiting NCT04204759 - Transcranial Direct Current Stimulation and Antisocial Behavior N/A
Completed NCT04625465 - Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence N/A
Recruiting NCT04164472 - NIH R01 Friend to Friend With Coaching N/A